Related Experiment Video
Updated: Jun 19, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Ethnic differences in pediatric systemic lupus erythematosus
Linda T Hiraki1, Susanne M Benseler, Pascal N Tyrrell
1Division of Rheumatology, Hospital for Sick Children, University of Toronto, Toronto, Canada.
Insights
Pediatric systemic lupus erythematosus (pSLE) is more prevalent in non-Caucasian children, who are diagnosed younger and more often develop kidney disease. However, disease activity and damage are independent of ethnicity.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Genetics and Epidemiology
Background:
- Systemic lupus erythematosus (SLE) exhibits ethnic variations in adults, but this is less understood in pediatric SLE (pSLE).
- Understanding ethnic disparities in pSLE is crucial for equitable healthcare and targeted interventions.
Purpose of the Study:
- To compare the prevalence and severity of major organ involvement, disease activity, and damage in pediatric SLE across different ethnic groups.
- To investigate the impact of ethnicity on the clinical presentation and disease course of pSLE.
Main Methods:
- An inception cohort of 265 pediatric SLE patients at Sick Kids Hospital was analyzed.
- Patients were categorized by self-designated ethnicity and compared to the Metropolitan Toronto at-risk population.
- Longitudinal data on organ involvement, disease activity (SLE Disease Activity Index), and damage were collected and compared among ethnic groups.
Main Results:
- Non-Caucasian patients constituted the majority (60%) of the pSLE cohort, a higher proportion than in the general population.
- Non-Caucasian patients were diagnosed at a younger age (12.6 years) compared to Caucasian patients (14.6 years).
- Renal disease (nephritis) was significantly more prevalent in non-Caucasian (62%) versus Caucasian (45%) pSLE patients.
Conclusions:
- Non-Caucasian ethnicity is linked to a higher prevalence of pediatric SLE.
- Younger age at diagnosis and increased likelihood of nephritis are associated with non-Caucasian ethnicity in pSLE.
- Disease activity and damage in pSLE are primarily associated with major organ involvement, irrespective of patient ethnicity.
Objective:
Prevalence and severity of systemic lupus erythematosus (SLE) in adults is suggested to be distinctly different between ethnic groups. The impact of ethnicity is not as well delineated in pediatric SLE (pSLE). We compared prevalence and extent of major organ involvement, disease activity, and damage in pSLE between different ethnic groups.
Methods:
Ethnic demographic profiles of an inception cohort of 265 patients with pSLE followed at Sick Kids Hospital in Toronto were determined and compared to the Metropolitan Toronto at-risk population. Patients were categorized into ethnic subsets based on self-designated ethnic origins. Disease characteristics including major organ involvement, disease activity, and damage measures were longitudinally determined and compared among ethnic groups.
Results:
Ethnicity data were available on 259/265 pSLE patients (99.6%); the majority were non-Caucasian (60%) compared to the Metropolitan Toronto at-risk population (40%) (p < 0.0001). Non-Caucasian patients were younger at diagnosis than Caucasian patients, Black patients being the youngest at diagnosis (12.6 vs 14.6 yrs; p = 0.007). Renal disease was significantly more common in non-Caucasian than in Caucasian pSLE patients (62% vs 45%; p = 0.01). There was a trend toward increased prevalence of central nervous system disease in Black patients compared to Asian patients (p = 0.108). There was no difference in gender ratio, SLE Disease Activity Index, or damage scores between ethnic groups.
Conclusion:
Non-Caucasian ethnicity is associated with increased pSLE disease prevalence. Non-Caucasian pSLE patients were significantly younger and more likely to have nephritis. However, disease activity and damage were strongly associated with major organ disease independent of the patient's ethnicity.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption